ask="N/A"
ask_size="N/A"
average_daily_volume="56748"
bid="12.15"
bid_size="100"
book_value="3.11"
change="-0.18"
change_from_200_day_moving_average="8.94"
change_from_50_day_moving_average="5.68"
change_from_52_week_high="-0.83"
change_From_52_week_low="17.82"
change_in_percent="-0.60%"
close="29.74"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.69"
ebitda="-67.56M"
eps_estimate_current_year="-2.37"
eps_estimate_next_quarter="-0.65"
eps_estimate_next_year="-2.35"
ex_dividend_date="N/A"
float_shares="11611000"
high="30.47"
high_52_weeks="30.57"
last_trade_date="3/3/2017"
last_trade_price="29.74"
last_trade_size="310"
last_trade_time="4:00pm"
low="29.51"
low_52_weeks="11.92"
market_capitalization="749.72M"
moving_average_200_day="20.80"
moving_average_50_day="24.06"
name="Ascendis Pharma A/S"
notes="N/A"
one_year_target_price="29.25"
open="30.00"
pe_ratio="N/A"
peg_ratio="-0.51"
percent_change_from_200_day_moving_average="+42.95%"
percent_change_from_50_day_moving_average="+23.59%"
percent_change_from_52_week_high="-2.72%"
percent_change_from_52_week_low="+149.50%"
previous_close="29.92"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="9.61"
price_per_sales="129.05"
revenue="5.84M"
shares_outstanding="25209000"
short_ratio="8.07"
stock_exchange="NMS"
symbol="ASND"
volume="28231"
weeks_range_52="11.92 - 30.57"
